908 Devices Launches MAVERICK, a Raman-Based PAT Solution for Real-Time Bioprocess Control
908 Devices Inc., a leading provider of handheld and desktop devices for chemical and biochemical analysis, has unveiled MAVERICK, an innovative optical in-line analyzer that offers real-time monitoring and control of glucose, lactate, and total biomass in mammalian cell cultures. This cutting-edge solution also provides rich process fingerprint data to support predictive bioprocess modeling on a large scale. MAVERICK is the first turn-key device to utilize Raman spectroscopy for bioprocess control without the need for complex modeling and development.
Unlike traditional Raman-based analyzers, MAVERICK eliminates the steep learning curve typically associated with such devices. It offers all the advantages of Raman spectroscopy without the high costs and complexities of conventional spectroscopic methods. With its purpose-built de novo models, MAVERICK can process Raman spectra from various culture media types and cell lines, delivering actionable process parameters or direct process control actions. The device also allows AI/ML experts to extend its capabilities for advanced predictive control of critical process parameters or quality attributes.
Dr. Seongkyu Yoon, a Professor at the University of Massachusetts-Lowell, praised MAVERICK for overcoming the challenges of traditional Raman spectroscopy. He highlighted the device’s ability to provide accurate measurements independently of cell line, media, and scale, which is highly beneficial for biopharmaceutical scientists and engineers.
The MAVERICK hub has the capability to monitor up to six bioreactor modules simultaneously, with independent analog/digital control of feed systems for each module. Additionally, the device supports remote real-time web access to bioreactor status and settings through the MAVERICK hub. This feature enables biopharmaceutical process development scientists and manufacturers to enhance their process understanding and implement dynamic control strategies more efficiently, resulting in faster time to market and more robust and efficient processes.
Christopher D. Brown, Chief Product Officer and co-founder of 908 Devices, emphasized the importance of tools like MAVERICK in the biopharmaceutical industry’s adoption of Process Analytical Technologies for the advancement of Biopharma 4.0. He stated that MAVERICK offers easy-to-integrate in-line analysis and control without the need for extensive expert configuration or set-up. Furthermore, as a spectroscopic-based device, MAVERICK can be extended to analyze other analytes and parameters.
To learn more about MAVERICK and 908 Devices’ suite of bioprocessing development devices, including MAVEN and REBEL, visit their website at 908devices.com.
About 908 Devices:
908 Devices is a Boston-based company revolutionizing chemical and biochemical analysis with its handheld and desktop devices. Their devices are designed to address critical applications in life sciences research, bioprocessing, pharma/biopharma, forensics, and other related markets. By combining mass spectrometry, microfluidic sampling and separations, software automation, and machine learning, 908 Devices provides quick, actionable answers to complex analytical challenges.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied. More information about these risks and uncertainties can be found in the Company’s filings with the Securities and Exchange Commission.
Source: Business Wire